Reactive arthritis that follows episodes of diarrhea, intestinal infection, or bowel inflammation is well documented in the medical literature. Several bacterial species have been associated with this type of arthritis, including Vibrio cholerae, Salmonella, Shigella, Yersinia, and Campylobacter. Intestinal inflammation also appears to play a role in inflammatory arthritis more broadly. Between 10% and 20% of patients with Crohn’s disease, for example, develop a reactive form of arthritis. A detailed discussion of the connection between gastrointestinal antigens and joint inflammation can be found in Antigens, the Gastrointestinal Tract and Arthritis (Inman RD, Rheumatic Disease Clinics of North America, May 1991;17(2):309–321).
Food sensitivity may also contribute to arthritis symptoms in some individuals. In a small study of 16 patients with rheumatoid arthritis (RA) who reported food-related symptom flares, three patients demonstrated both subjective and objective worsening of arthritis symptoms during blinded, controlled food challenges. These patients were asymptomatic when the offending foods were avoided. While this was a small study, it suggests that elimination diets may be helpful for a subset of RA patients. Additional support for a gut–joint connection comes from research suggesting that metabolic products from intestinal bacteria may contribute to joint inflammation (Intestinal Flora, Bacteria and Arthritis: Why the Joint, Hazenberg MP, Scandinavian Journal of Rheumatology, 1995;24(Suppl 101):207–211).
Further evidence comes from a study examining small intestinal bacterial overgrowth (SIBO) in patients with rheumatoid arthritis (Small Intestinal Bacterial Overgrowth in Patients With Rheumatoid Arthritis, Henriksson AEK et al, Annals of the Rheumatic Diseases, 1993;52:503–510). In this study of 25 patients who tested positive for rheumatoid factor, eight (32%) were found to have low or absent stomach acid production (hypochlorhydria or achlorhydria). Among individuals with inadequate stomach acid, bacterial overgrowth in the small intestine was present in both RA patients and controls. However, among those with normal stomach acid production, none of the controls had bacterial overgrowth, while 35% of the RA patients did. The authors concluded that abnormal bacterial colonization of the small intestine may be associated with rheumatoid arthritis.
Taken together, these findings suggest that intestinal health may influence inflammatory joint disease in at least some patients. Dietary approaches that support a healthy balance of gut flora—such as elimination diets or plant-based diets—may be beneficial for certain individuals with RA. Increasing vegetable intake, identifying and avoiding food sensitivities, and supporting normal digestive function, including adequate enzyme and stomach acid production, may help maintain a healthier intestinal environment.
These observations are based on small studies and clinical correlations rather than definitive proof. However, it is worth remembering that many major medical advances began with modest observations. Early reports that mold inhibited bacterial growth initially drew little attention, yet they ultimately laid the groundwork for the development of penicillin. Similarly, emerging insights into the gut–joint connection may help guide future research into inflammatory arthritis.
